Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches

Journal Article · · Neural Regeneration Research
 [1];  [2]
  1. Los Alamos National Laboratory (LANL), Los Alamos, NM (United States); St. Georges University School of Medicine (Grenada)
  2. University of Otago, Dunedin (New Zealand)
A review of recent animal models of amyotrophic lateral sclerosis showed a large number of miRNAs had altered levels of expression in the brain and spinal cord, motor neurons of spinal cord and brainstem, and hypoglossal, facial, and red motor nuclei and were mostly upregulated. Among the miRNAs found to be upregulated in two of the studies were miR-21, miR-155, miR-125b, miR-146a, miR-124, miR-9, and miR-19b, while those downregulated in two of the studies included miR-146a, miR-29, miR-9, and miR-125b. A change of direction in miRNA expression occurred in some tissues when compared (e.g., miR-29b-3p in cerebellum and spinal cord of wobbler mice at 40 days), or at different disease stages (e.g., miR-200a in spinal cord of SOD1(G93A) mice at 95 days vs. 108 and 112 days). In the animal models, suppression of miR-129-5p resulted in increased lifespan, improved muscle strength, reduced neuromuscular junction degeneration, and tended to improve motor neuron survival in the SOD1(G93A) mouse model. Suppression of miR-155 was also associated with increased lifespan, while lowering of miR-29a tended to improve lifespan in males and increase muscle strength in SOD1(G93A) mice. Overexpression of members of miR-17~92 cluster improved motor neuron survival in SOD1(G93A) mice. Treatment with an artificial miRNA designed to target hSOD1 increased lifespan and improved muscle strength in SOD1(G93A) animals. Further studies with animal models of amyotrophic lateral sclerosis are warranted to validate these findings and identify specific miRNAs whose suppression or directed against hSOD1 results in increased lifespan, improved muscle strength, reduced neuromuscular junction degeneration, and improved motor neuron survival in SOD1(G93A) animals.
Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE National Nuclear Security Administration (NNSA)
Grant/Contract Number:
89233218CNA000001
OSTI ID:
2470445
Journal Information:
Neural Regeneration Research, Journal Name: Neural Regeneration Research Journal Issue: 4 Vol. 17; ISSN 1673-5374
Publisher:
Chinese Association of Rehabilitation Medicine (CARM)Copyright Statement
Country of Publication:
United States
Language:
English

References (135)

Rodent Models of Amyotrophic Lateral Sclerosis journal June 2015
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) journal March 2012
TDP43 mutation in familial amyotrophic lateral sclerosis journal April 2008
Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 mice journal November 2014
Adeno‐associated virus–delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model journal March 2016
MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS journal May 2012
Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis journal June 1994
Dysregulation of microRNA biogenesis machinery and microRNA/RNA ratio in skeletal muscle of amyotrophic lateral sclerosis mice journal December 2017
Impairment of retrograde axonal transport in wobbler mouse motor neuron disease journal February 1990
p53 Is Abnormally Elevated and Active in the CNS of Patients with Amyotrophic Lateral Sclerosis journal December 2000
A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis journal January 1987
Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis journal January 2000
Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis journal February 2011
Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion journal September 2012
The wobbler mouse, an ALS animal model journal March 2013
miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients journal August 2014
Chronic Exposure to Dietary Sterol Glucosides is Neurotoxic to Motor Neurons and Induces an ALS–PDC Phenotype journal January 2008
Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients journal April 2016
Increased Expression of MicroRNA-29a in ALS Mice: Functional Analysis of Its Inhibition journal April 2014
Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage journal June 2017
Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model journal July 2018
The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies journal October 1997
Amyotrophic lateral sclerosis journal March 2011
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study journal May 2013
Amyotrophic lateral sclerosis: moving towards a new classification system journal October 2016
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial journal July 2017
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications journal January 2018
Implementation of a manual for working with wobbler mice and criteria for discontinuation of the experiment journal July 2015
Sporadic and hereditary amyotrophic lateral sclerosis (ALS) journal April 2015
Vulnerability of microRNA biogenesis in FTD–ALS journal September 2016
Mouse models of ALS: Past, present and future journal August 2018
Therapeutic Development in Amyotrophic Lateral Sclerosis journal March 2015
Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: A longitudinal MRI study journal September 2011
Altered miRNA expression is associated with neuronal fate in G93A-SOD1 ependymal stem progenitor cells journal March 2014
Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms journal March 2016
The ‘Omics’ of Amyotrophic Lateral Sclerosis journal January 2016
Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis journal January 2013
Serum microRNAs in sporadic amyotrophic lateral sclerosis journal September 2015
Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration journal July 2011
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD journal October 2011
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS journal October 2011
C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD journal December 2015
Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice journal December 2015
C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD journal May 2016
Absence of Survival and Motor Deficits in 500 Repeat C9ORF72 BAC Mice journal November 2020
Wobbler mice modeling motor neuron disease display elevated transactive response DNA binding protein journal January 2009
Intralingual and Intrapleural AAV Gene Therapy Prolongs Survival in a SOD1 ALS Mouse Model journal June 2020
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis journal July 2020
Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration journal August 2019
Treatment of a Mouse Model of ALS by In Vivo Base Editing journal April 2020
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study journal January 2012
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis journal March 1993
MicroRNA-125b regulates microglia activation and motor neuron death in ALS journal January 2016
FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment journal December 2012
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis journal May 2015
C9orf72 nucleotide repeat structures initiate molecular cascades of disease journal March 2014
Decoding ALS: from genes to mechanism journal November 2016
MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity journal December 2015
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis journal March 2008
Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse journal October 2005
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses journal August 2004
MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathway journal December 2010
State of play in amyotrophic lateral sclerosis genetics journal December 2013
Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF journal February 2006
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis journal February 2008
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis journal November 2011
The epidemiology of ALS: a conspiracy of genes, environment and time journal October 2013
The phenotypic variability of amyotrophic lateral sclerosis journal October 2014
Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era journal April 2015
The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a journal June 2007
Transgenic-Mouse Model of Amyotrophic Lateral Sclerosis journal December 1994
Amyotrophic Lateral Sclerosis journal July 2017
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) journal January 2002
Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis journal July 2007
miRNA malfunction causes spinal motor neuron disease journal June 2010
Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis journal October 2011
TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes journal February 2012
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43 journal February 2013
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS journal December 2013
Mitochondrial Dysfunction and Decrease in Body Weight of a Transgenic Knock-in Mouse Model for TDP-43 journal April 2014
A20: Central Gatekeeper in Inflammation and Immunity journal March 2009
SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management journal January 2008
Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20 journal February 2008
Therapeutic rAAVrh10 MediatedSOD1Silencing in AdultSOD1G93AMice and Nonhuman Primates journal January 2016
Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor journal December 1998
Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease journal May 2009
Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice journal June 2013
l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND journal January 2020
The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse journal March 2016
New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models journal March 2016
Nuclear factor TDP‐43 can affect selected microRNA levels journal April 2010
Screening the expression characteristics of several miRNAs in G93A‐SOD1 transgenic mouse: altered expression of miRNA‐124 is associated with astrocyte differentiation by targeting Sox2 and Sox9 journal November 2017
In vivo genome editing improves motor function and extends survival in a mouse model of ALS journal December 2017
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis journal March 2008
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 journal February 2009
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis journal February 2009
MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice journal December 2009
Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques journal October 2018
MicroRNA-125b Promotes Neuronal Differentiation in Human Cells by Repressing Multiple Targets journal October 2009
An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'. journal December 1968
Motor Neuron Diversity in Development and Disease journal June 2010
Unraveling the Mechanisms Involved in Motor Neuron Degeneration in als journal July 2004
ALS and Frontotemporal Dysfunction: A Review journal January 2012
Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization journal January 2016
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS journal September 2012
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models journal July 2018
Advances in spinal muscular atrophy therapeutics journal January 2018
Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: Implications for human motor neuron disease journal March 2011
Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels journal May 2013
Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model journal November 2015
Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage journal January 2015
Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis journal October 2015
Analysis of microRNA from archived formalin-fixed paraffin-embedded specimens of amyotrophic lateral sclerosis journal December 2014
Presymptomatic ALS genetic counseling and testing journal June 2016
Protein Aggregation and Protein Instability Govern Familial Amyotrophic Lateral Sclerosis Patient Survival journal July 2008
MicroRNA 146a (miR-146a) Is Over-Expressed during Prion Disease and Modulates the Innate Immune Response and the Microglial Activation State journal February 2012
Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset journal September 2013
Analysis of Novel NEFL mRNA Targeting microRNAs in Amyotrophic Lateral Sclerosis journal January 2014
The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease journal October 2015
The Wobbler Mouse: A Neurodegeneration Jigsaw Puzzle journal January 2003
Behavioral and Neurological Correlates of ALS-Parkinsonism Dementia Complex in Adult Mice Fed Washed Cycad Flour journal January 2002
Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice journal August 2010
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models journal April 2017
Dysregulated mi RNA biogenesis downstream of cellular stress and ALS ‐causing mutations: a new mechanism for ALS journal September 2015
The Role of Immune and Inflammatory Mechanisms in ALS journal April 2011
MicroRNAs: Newcomers into the ALS Picture journal March 2015
PTEN: A molecular target for neurodegenerative disorders journal January 2012
The Emerging Roles of MicroRNAs in the Pathogenesis of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis (FTD-ALS) Spectrum Disorders journal February 2014
RNA metabolism in ALS: When normal processes become pathological journal February 2014
Neuronal dark matter: the emerging role of microRNAs in neurodegeneration journal January 2013
The role of miRNA in motor neuron disease journal January 2014
Microglia centered pathogenesis in ALS: insights in cell interconnectivity journal May 2014
Muscle Expression of SOD1G93A Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice journal December 2015
Deregulated miR-29b-3p Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis journal September 2019
Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS journal January 2016